Click to Share

Filter News
Show All Results
News By Country
None Found
News By Tag
Sanofi Company Remove

October 2016

Public Company News

Business Press Releases

Sanofi Company Press Releases

Exclusive News
Topics Locations Industries Dates

By Mary Ann Liebert, Inc., publishers
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.

Page updated every 10 minutes

Like PRLog?
Click to Share